Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)

Strom, Brian L., Eng, Sybil M., Faich, Gerald, Reynolds, Robert F., D'Agostino, Ralph B., Ruskin, Jeremy, Kane, John M.·2011·American Journal of Psychiatry
DOI 10.1176/appi.ajp.2010.08040484

Cited by (122)

Items 101–122 of 122

  1. The Impact of Cardiometabolic Risk in Patients with Severe Mental Illness: From Evidence to Clinical Management
    Guido Di, Salvatore Calò · 2011 · InTech eBooks
  2. Cardiovascular risk factors and pharmacogenetics of clozapine in schizophrenia
    Eric Olsson · 2015 · Figshare
  3. The Use of Randomized Controlled Trials in Pharmacoepidemiology
    Robert F. Reynolds, Samuel M. Lesko, Nicolle M. Gatto, Tjeerd Pieter van Staa, Allen A. Mitchell · 2019 · Pharmacoepidemiology
  4. Schizophrenia and Related Psychoses
    2025 · Wiley eBooks
  5. The Role of Pharmacoepidemiology in Industry
    Jingping Mo, Nicolle M. Gatto, Rachel E. Sobel, Robert F. Reynolds · 2012 · Pharmacoepidemiology
  6. Views from Academia, Industry, Regulatory Agencies, and the Legal System
    J. Avorn, Jingping Mo, R. Reynolds, G. Dal Pan, P. Arlett, A. Kesselheim · 2013 · Textbook of Pharmacoepidemiology
  7. Response to Vieweg and Hasnain Letter
    Brian L. Strom · 2011 · American Journal of Psychiatry
  8. Regional disease characteristics and comorbidities of patients with schizophrenia in the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Findings from an international large simple trial
    John Michael Kane, Wolfgang Fleischhacker, Francesca M. Kolitsopoulos, Onur N. Karayal, Jamie L. Geier, CYNTHIA O. SIU, Robert Reynolds, Gerald A. Faich, Brian L. Strom · 2012 · Open Journal of Psychiatry
  9. Epidemiology in Drug Development
    Catherine Sigler, Annette Stemhagen · 2011
  10. World Psychiatryis indexed in PubMed, Current Contents/Clinical Medicine, Current Contents/Social and Behavioral Sciences, Science Citation Index, and EMBASE Âñåìèðíàÿ Ïñèõèàòðè÷åñêàÿ Àññîöèàöèÿ (ÂÏÀ)
    Mario Maj, Èçáðàííûé Ïðåçèäåíò, Allan Tasman, Helen Herrman · 2011
  11. ВИВЧЕННЯ УМОВ ІЗОЛЮВАННЯ ЗИПРАЗИДОНУ З ОБ’ЄКТІВ БІОЛОГІЧНОГО ПОХОДЖЕННЯ
    S. I. Davidovich, I. J. Halkevych · 2017 · Фармацевтичний часопис
  12. The Prevalence and Significance of Antipsychotic Dosing on QTc Prolongation
    Shannon DeGrote, Michael D. Shuman, Shaiza Khan · 2017 · Journal of Psychology Research
  13. The Use of Randomized Controlled Trials for Pharmacoepidemiology
    Samuel M. Lesko, Allen A. Mitchell, Robert F. Reynolds · 2021
  14. Clinical News
    P.F. Buckley · 2011 · Clinical Schizophrenia & Related Psychoses
  15. Antipsychotic drugs
    Alfonso Carvajal, Luis H. Martín Arias · 2012 · Side effects of drugs annual
  16. QTc Prolongation
    Aniyizhai Annamalai · 2017 · Springer eBooks
  17. Bibliography: Schizophrenia
    2012 · FOCUS The Journal of Lifelong Learning in Psychiatry
  18. Ziprasidone
    2015 · Elsevier eBooks
  19. Antipsychotic Drugs
    Shreedhar Paudel, Carol Lim, Oliver Freudenreich · 2024 · Elsevier eBooks
  20. Antipsychotic Drugs
    Shreedhar Paudel, Carol Lim, Oliver Freudenreich · 2024 · Elsevier eBooks
  21. The Interaction Mechanism of Ziprasidone With Calf Thymus DNA by Multiple Spectrums And Molecular Docking
    Xiaoyun Li, Xuechao Wang, Ruo-Hui Gao, Xiaojuan Chen, Jingjing Lu · 2025 · SSRN Electronic Journal
  22. Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies
    Nisrine Haddad, Nawal Farhat, Christopher A. Gravel, Yue Chen, Franco Momoli, Donald R. Mattison, Jeannette Goguen, Daniel R. Krewski · 2026 · Journal of Clinical Medicine